There are 2789 resources available
1864P - Expertise for management of immune-related adverse events in cancer therapy: Mapping of French practices
Presenter: Valentin Coudert
Session: ePoster Display
1865P - Impact of multidisciplinary tumor board (MTB) in the treatment of liver-limited metastasis from colorectal cancer (LMCRC)
Presenter: Tiago Felismino
Session: ePoster Display
1866P - A risk signature of four autophagy-related genes for predicting neuroblastoma survival is associated with tumor immune
Presenter: Wenjuan Kang
Session: ePoster Display
1867P - An overview of RAD51C pathogenic variants in Mexican patients with breast cancer
Presenter: Javier Castorena Ibarra
Session: ePoster Display
1868P - Real-world safety of the 6-weekly pembrolizumab regimen in cancer patients treated in South East London
Presenter: Matthaios Kapiris
Session: ePoster Display
1869TiP - A phase II, multicenter, open-label study evaluating trastuzumab deruxtecan (T-DXd) for the treatment of select HER2-expressing solid tumors (DESTINY-PanTumor02)
Presenter: Funda Meric-Bernstam
Session: ePoster Display
1870TiP - Tazemetostat in combination with a PARP Inhibitor or checkpoint inhibitor in patients (Pts) with solid tumors
Presenter: Charles Rudin
Session: ePoster Display
1871TiP - PLATON – “Platform for Analyzing Targetable Tumor Mutations”: A pilot study
Presenter: Arndt Vogel
Session: ePoster Display
CN4 - Evaluation of the effectiveness of technology-based psychosocial education and counseling program for adolescent leukemia survivors: A randomised controlled trial
Presenter: Tuba Arpaci
Session: ePoster Display
CN5 - Wearable technology is it the future?
Presenter: Louise Cave
Session: ePoster Display